Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Silk

Showing results (1251-1260 of 1,449) with videos related to

Pageof 145
Sort By:
Lancet (London, England)|February 27, 2023
Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 3 trial (SLE-BRAVE-II)Michelle Petri, Ian N Bruce, Thomas Dörner, et al.
Applied Physiology, Nutrition, and Metabolism = Physiologie Appliquee, Nutrition Et Metabolisme|January 16, 2016
Balancing ballistic protection against physiological strain: evidence from laboratory and field trialsNigel A S Taylor, Catriona A Burdon, Anne M J van den Heuvel, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 11, 2003
High avidity antigen-specific CTL identified by CD8-independent tetramer stainingEd Man-Lik Choi, Ji-Li Chen, Linda Wooldridge, et al.
Lancet (London, England)|February 27, 2023
Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 3 trial (SLE-BRAVE-I)Eric F Morand, Edward M Vital, Michelle Petri, et al.
Epidemiology and Infection|January 5, 2012
Eight years of Legionnaires' disease transmission in travellers to a condominium complex in Las Vegas, NevadaB J Silk, M R Moore, M Bergtholdt, et al.
Cell Reports. Medicine|August 2, 2021
Antibodies from malaria-exposed Malians generally interact additively or synergistically with human vaccine-induced RH5 antibodiesAlexandra C Willcox, Alex S Huber, Ababacar Diouf, et al.
Behavior Therapy|January 15, 2025
Targeted Sleep Enhancement Reduces Residual Anxiety Symptoms in Peri-Adolescents Previously Treated for Anxiety DisordersSaima A Akbar, Timothy Hayes, Matthew J Valente, et al.
MMWR. Morbidity and Mortality Weekly Report|February 2, 2023
Spike Gene Target Amplification in a Diagnostic Assay as a Marker for Public Health Monitoring of Emerging SARS-CoV-2 Variants - United States, November 2021-January 2023Heather M Scobie, Akilah R Ali, Philip Shirk, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|October 3, 2018
Modifying the Impact of Eveningness Chronotype ("Night-Owls") in Youth: A Randomized Controlled TrialAllison G Harvey, Kerrie Hein, Emily A Dolsen, et al.
Cancer Medicine|August 16, 2014
The impact of genetic heterogeneity on biomarker development in kidney cancer assessed by multiregional samplingAlexander Sankin, Abraham A Hakimi, Nina Mikkilineni, et al.
Pageof 145

Showing results (1251-1260 of 1,449) with videos related to

Sort By:
Pageof 145
Lancet (London, England)|February 27, 2023
Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 3 trial (SLE-BRAVE-II)Michelle Petri, Ian N Bruce, Thomas Dörner, et al.
Applied Physiology, Nutrition, and Metabolism = Physiologie Appliquee, Nutrition Et Metabolisme|January 16, 2016
Balancing ballistic protection against physiological strain: evidence from laboratory and field trialsNigel A S Taylor, Catriona A Burdon, Anne M J van den Heuvel, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 11, 2003
High avidity antigen-specific CTL identified by CD8-independent tetramer stainingEd Man-Lik Choi, Ji-Li Chen, Linda Wooldridge, et al.
Lancet (London, England)|February 27, 2023
Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 3 trial (SLE-BRAVE-I)Eric F Morand, Edward M Vital, Michelle Petri, et al.
Epidemiology and Infection|January 5, 2012
Eight years of Legionnaires' disease transmission in travellers to a condominium complex in Las Vegas, NevadaB J Silk, M R Moore, M Bergtholdt, et al.
Cell Reports. Medicine|August 2, 2021
Antibodies from malaria-exposed Malians generally interact additively or synergistically with human vaccine-induced RH5 antibodiesAlexandra C Willcox, Alex S Huber, Ababacar Diouf, et al.
Behavior Therapy|January 15, 2025
Targeted Sleep Enhancement Reduces Residual Anxiety Symptoms in Peri-Adolescents Previously Treated for Anxiety DisordersSaima A Akbar, Timothy Hayes, Matthew J Valente, et al.
MMWR. Morbidity and Mortality Weekly Report|February 2, 2023
Spike Gene Target Amplification in a Diagnostic Assay as a Marker for Public Health Monitoring of Emerging SARS-CoV-2 Variants - United States, November 2021-January 2023Heather M Scobie, Akilah R Ali, Philip Shirk, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|October 3, 2018
Modifying the Impact of Eveningness Chronotype ("Night-Owls") in Youth: A Randomized Controlled TrialAllison G Harvey, Kerrie Hein, Emily A Dolsen, et al.
Cancer Medicine|August 16, 2014
The impact of genetic heterogeneity on biomarker development in kidney cancer assessed by multiregional samplingAlexander Sankin, Abraham A Hakimi, Nina Mikkilineni, et al.
Pageof 145